Alle Studien
RekrutierungNAINTERVENTIONELL

Neurofeedback for Nociplastic Pain in Rheumatoid Arthritis (NECTAR)

This study, called NECTAR, is exploring a new treatment for people with rheumatoid arthritis (RA) who experience ongoing pain, even when their inflammation is under control. This type of pain is called nociplastic pain and is similar to the pain felt in fibromyalgia. There aren't many good treatments for it right now. The study will use a non-invasive method called neurofeedback. This involves learning to control your brainwaves. Previous research suggests this might help with fibromyalgia. Researchers want to see if neurofeedback can reduce this specific pain in RA patients, and also improve related symptoms like tiredness and poor sleep.

Auf einen Blick

Status
Rekrutierung
Phase
NA
Sponsor
NHS Greater Glasgow and Clyde
Einschreibeziel
16
Starten
24. Juni 2024
Geschätzte Fertigstellung
29 Jan 2027

Worum geht es in dieser Studie?

Rheumatoid arthritis (RA) is a condition where your body's immune system mistakenly attacks your joints, causing pain and swelling. While treatments often help reduce the swelling, some people continue to experience persistent pain. This kind of pain, called nociplastic pain, feels similar to the wide-ranging pain experienced in a condition called fibromyalgia. Unfortunately, there aren't many effective treatments specifically for this persistent pain in RA.

This study, called NECTAR, is investigating a promising new approach called neurofeedback. Think of neurofeedback as a way to train your brain. It's a non-invasive technique where you learn to adjust your brain activity. Researchers have seen some positive results with neurofeedback helping people with fibromyalgia, and now they want to see if it can help people with RA who have this similar type of pain.

The main goal of NECTAR is to see if neurofeedback can directly reduce this nociplastic pain in people with RA. Beyond pain, the study will also look at how neurofeedback might affect other common and difficult symptoms, such as feeling very tired (fatigue) and having trouble sleeping.

Wichtige Erkenntnisse

  • Exploring neurofeedback for persistent pain in RA.
  • Non-invasive brain training method.
  • Aims to reduce pain, fatigue, and improve sleep.
  • Study lasts approximately 11-13 weeks.
  • No medication changes required for the study.

Wer könnte berechtigt sein?

To be part of this study, you need to have been diagnosed with rheumatoid arthritis by specific medical guidelines. You also need to experience widespread, long-lasting pain, meeting another set of medical criteria, and your rheumatoid arthritis needs to be stable, meaning your swelling and inflammation levels are low.

There are also some other requirements. You should have normal or corrected vision and hearing, be right-handed, and experience pain that is at least a 4 out of 10 on a pain scale. Participants must be between 18 and 75 years old.

You won't be able to join if you have certain neurological conditions like MS or Parkinson's, or any major mental health conditions that would make taking part difficult. The study also cannot accept you if you're currently receiving intensive pain management from a specialist team, or are involved in other research studies that might interfere with this one.

Könnte diese Studie für Sie geeignet sein?

Beantworten Sie diese kurzen Fragen, um zu sehen, ob Sie möglicherweise berechtigt sind. Dies ist nur ein Leitfaden – das Forschungsteam trifft die endgültige Entscheidung.

  1. Do I have a diagnosis of rheumatoid arthritis?
  2. Do I also experience widespread, long-lasting pain?
  3. Is my rheumatoid arthritis currently stable (low inflammation)?
  4. Am I aged between 18 and 75?
  5. Do I feel my pain is at least a 4 out of 10?
  6. Do I not have other major brain or mental health conditions?
Beantworten Sie jede Frage, um Ihr Ergebnis zu sehen.

Was beinhaltet die Teilnahme?

If you decide to take part in this study, the whole process will last about 11 to 13 weeks. Before starting, you'll record your pain, sleep, and tiredness for one week. Then, you'll have 10 neurofeedback sessions, usually 2 to 3 times a week. Each session involves having sensors placed on your head to measure brain activity; this takes about 5 to 10 minutes to set up. You'll then sit comfortably and watch a screen that shows your brain activity as coloured bars. Your task will be to try and change these bars by learning to control certain brainwaves, aiming to decrease some and increase others. Each training period lasts 30 minutes. After your 10 sessions, there will be a final in-person assessment, and then a follow-up chat over the phone or online one month later.

If you have a short-term illness like a cold, flu, or COVID-19, your sessions can be delayed for up to a week. However, if you miss more than two sessions in total, you might need to leave the study.

Potenzielle Risiken und Vorteile

This study aims to discover if neurofeedback can offer a new way to manage nociplastic pain, fatigue, and sleep problems in people with rheumatoid arthritis. While there are no guarantees, a potential benefit is a reduction in these challenging symptoms. Neurofeedback is a non-invasive technique, meaning it doesn't involve medicines or surgery, and is generally considered safe. You have the right to withdraw from the study at any time, for any reason, without it affecting your medical care.

Standorte (1)

  • Clinical Research Facility (CRF), Queen Elizabeth University Hospital
    Verifizierte Postleitzahl
    Glasgow, Vereinigtes Königreich· Rekrutierung

Häufige Fragen

What is neurofeedback?

Neurofeedback is a type of brain training where you learn to control your own brain activity, often with the help of a monitor showing your brainwaves.

Is neurofeedback painful?

No, neurofeedback is not painful. It involves placing sensors on your scalp to measure brain activity, but no electricity is put into your brain.

Wie lange muss ich beteiligt sein?

The study will require your participation for about 11 to 13 weeks in total.

What if I miss a session?

Sessions can be postponed for up to a week for short-term illness. However, if you miss more than two sessions, you may need to stop participating in the study.

Will I stop my current RA medications?

No, the study does not involve changing your existing rheumatoid arthritis medications. You should continue them as prescribed by your doctor.

Wie Sie mehr erfahren können

Aleksandra Vuckovic, PhD

Sprechen Sie immer mit Ihrem Hausarzt oder Spezialisten, bevor Sie sich entscheiden, an einer Studie teilzunehmen.

Interessiert daran, teilzunehmen?

Registrieren Sie Ihr Interesse

Teilen Sie Ihre Details und das Forschungsteam für "Neurofeedback for Nociplastic Pain in Rheumatoid Arthritis (… wird Sie kontaktieren, wenn Sie möglicherweise infrage kommen. Sprechen Sie immer mit Ihrem Hausarzt, bevor Sie zustimmen, teilzunehmen.

Diskussion

Community-Diskussion

Bereitgestellt von unserem Forum bei community.patient.info. Bitte seien Sie respektvoll — dies ist kein medizinischer Rat.